J. Woortman

Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes.

B. Kuster, S. Knapp, E. Salah, 2022, Journal of medicinal chemistry.

Decrypting drug actions and protein modifications by dose- and time-resolved proteomics

Thomas A. Hopf, Florian P Bayer, B. Kuster, 2023, Science.

Illuminating phenotypic drug responses of sarcoma cells to kinase inhibitors by phosphoproteomics

A. Sakhteman, Kerstin Putzker, Florian P. Bayer, 2023, Molecular systems biology.